Citadel Advisors
LHDX

Citadel Advisors’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Citadel Advisors’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– – – 15925
2022
Q3 		– Hold
0
– – – 14359
2022
Q2 		– Hold
0
– – – 14915
2022
Q1 		– Sell
-35,544
Closed -$175K – 15283
2021
Q4 		$306K Sell
35,544
-15,838
-31% -$101K ﹤0.01% 10877
2021
Q3 		$391K Buy
+51,382
New +$433K ﹤0.01% 10464
2021
Q2 		– Sell
-16,120
Closed -$102K – 14911
2021
Q1 		$195K Buy
+16,120
New +$320K ﹤0.01% 11737

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $867M AUM 16.97% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $342M AUM 17.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return